Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01509924
Other study ID # Tiohundra
Secondary ID
Status Active, not recruiting
Phase N/A
First received June 7, 2011
Last updated September 15, 2014
Start date May 2010
Est. completion date July 2015

Study information

Verified date September 2014
Source Tiohundra AB
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review BoardSweden: The National Board of Health and Welfare
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether Physical Activation on Prescription can help patients with TIA to become more physically active.

One group will receives Physical Activation on Prescription (PaP)and the other group will receives usual care.

And to identify if persons with TIA presents with cognitive impairments.


Description:

Transient ischemic attack (TIA) is a transient episode of neurologic dysfunction caused by ischemia, i.e. loss of blood flow. The symptoms of a TIA typically resolve within 24 hours. Attacks lasting more than 30 minutes are unusual. TIAs and strokes present with the same symptoms such as sudden weakness, numbness, sudden dimming or loss of vision, aphasia, slurred speech, facial palsy and mental impairments. Subtle problems with cognitive functions and fatigue may not always be addressed before discharge. However, even subtle mental impairments are important to identify, given the problems they might pose.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date July 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Understand Swedish language (also in and writing), living in Norrtälje community,

- To participate in the assessment of cognitive function: no known cognitive impairments before the TIA event and history of stroke.

Exclusion Criteria:

- Presence of contraindications to exercise, and no history of stroke

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Physical activation on Prescription
The advice on physical activity is patient oriented and based on FYSS (FYSS is a information bank that summarizes the up-to-date scientific knowledge on how to prevent and treat various diseases and conditions using physical activity). An individual prescription on physical activity is issued. The prescription form reminds of an ordinary drug prescription and provides specified types of physical activities including intensity, frequency and duration of the respective activities. The prescribed physical activity could be either self-monitored or organized by public physical activity organizations.

Locations

Country Name City State
Sweden Tiohundra Norrtälje Stockholms Läns Landsting

Sponsors (2)

Lead Sponsor Collaborator
Tiohundra AB Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Physical activity over time Physical activity measured with accelerometer (Time frame: Baseline, 3, 6, and 12 month). at discharge from hospital, 3, 6 and 12 month after the event No
Secondary Change in Cognition and Mental Fatigue Change in mental conditions over time measured with self report of mental fatigue and related symptoms. This is a scale with 7 different steps for graduate mental fatigue. Less points indicate less mental fatigue. All measures at baseline 3, 6 and 12 month after the event No
Secondary Change in 6 MWT Change in Walking endurance measured in 3, 6, 12 month measured with 6 MWT (six minutes Walking Test). 3, 6 and 12 months No
Secondary Change in self reported stages of change A self reported questionnaire that measures willingness to changes in physical activity over time. The scale has different levels of willingness for changes in physical activity. 3, 6, 12 months No
Secondary Change from baseline in systolic blood pressure at 12 months 3, 6, 12 months No
Secondary BMI Body Mass Index is measured at the start and at the end of the study 12 months No
Secondary Change in mental capacity over a period of time Change in mental capacity measured with a assessment called Cognistat that indicates four different levels of mental capacity. 3, 6,12 months No
Secondary Change in mental capacity over a period of time Change in mental capacity measured with a assessment called Cognistat that indicates four different levels of mental capacity. 3, 6, 12 months No
See also
  Status Clinical Trial Phase
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Recruiting NCT02662751 - Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA N/A
Completed NCT02038725 - MIDNOR-TIA - a Study of 600 Patients With Transient Ischemic Attack
Completed NCT01528462 - Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
Withdrawn NCT00069069 - E-Selectin Nasal Instillation to Prevent Secondary Stroke Phase 1
Recruiting NCT02701998 - The Stroke and Exercise Program N/A
Completed NCT02450760 - Connected Health Blood Pressure Monitoring In Stroke and TIA Patients N/A
Completed NCT02089074 - Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack N/A
Completed NCT00250380 - The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study) Phase 4
Terminated NCT00991029 - Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial Phase 3
Recruiting NCT06407154 - Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study, 2nd Wave
Completed NCT00061022 - Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Phase 3
Completed NCT02415855 - Canadian Pradaxa Acute Stroke Safety Study
Completed NCT02799511 - Biomarkers for the Diagnosis of Transient Ischemic Attack N/A
Completed NCT00514800 - Home Blood Pressure Monitoring Trial Phase 3
Recruiting NCT00553241 - Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score N/A
Active, not recruiting NCT00201461 - Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO) Phase 2/Phase 3
Completed NCT00119626 - Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke Phase 3
Terminated NCT05961163 - Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study
Completed NCT00590980 - Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) N/A